EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Systems pharmacology modeling in neuroscience: Prediction and outcome of PF-04995274, a 5-HT4 partial agonist, in a clinical scopolamine impairment trial

Timothy Nicholas, Sridhar Duvvuri, Claire Leurent, David Raunig, Tracey Rapp, Phil Iredale, Carolyn Rowinski, Robert Carr, Patrick Roberts, Athan Spiros, Hugo Geerts

Advances in Alzheimer's Disease · 2013

DOI: 10.4236/aad.2013.23012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Alzheimer's Disease, 2013. Verfasst von Timothy Nicholas und 10 weiteren Autor:innen. Die Arbeit wurde bisher 31-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Nicholas, T., Duvvuri, S., Leurent, C., Raunig, D., Rapp, T., Iredale, P., Rowinski, C., Carr, R., Roberts, P., Spiros, A., & Geerts, H. (2013). Systems pharmacology modeling in neuroscience: Prediction and outcome of PF-04995274, a 5-HT4 partial agonist, in a clinical scopolamine impairment trial. Advances in Alzheimer's Disease. https://doi.org/10.4236/aad.2013.23012

Vancouver

Nicholas T, Duvvuri S, Leurent C, Raunig D, Rapp T, Iredale P, et al. Systems pharmacology modeling in neuroscience: Prediction and outcome of PF-04995274, a 5-HT4 partial agonist, in a clinical scopolamine impairment trial. Advances in Alzheimer's Disease. 2013. doi:10.4236/aad.2013.23012

BibTeX
@article{Nicholas2013,
  author = {Nicholas, Timothy and Duvvuri, Sridhar and Leurent, Claire and Raunig, David and Rapp, Tracey and Iredale, Phil and Rowinski, Carolyn and Carr, Robert and Roberts, Patrick and Spiros, Athan and Geerts, Hugo},
  title = {Systems pharmacology modeling in neuroscience: Prediction and outcome of PF-04995274, a 5-HT4 partial agonist, in a clinical scopolamine impairment trial},
  journal = {Advances in Alzheimer's Disease},
  year = {2013},
  doi = {10.4236/aad.2013.23012}
}
Kostenlos starten →